TBPH
Theravance Biopharma Inc
17.00$
+0.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1,498.6% | -400.8% | -203.5% | -1,306.7% | -187.0% | -324.5% | -348.5% | -375.8% | -364.2% | -47.0% | -17.9% | 222.0% | |
| 22.8% | 7.1% | 6.4% | 26.2% | 5.2% | 8.5% | 12.6% | 15.5% | 13.7% | 7.4% | 5.6% | 5.2% | |
| 369.9% | 128.3% | 84.6% | 319.4% | 85.0% | 82.3% | 87.6% | 112.2% | 77.4% | 44.2% | 33.2% | 17.2% | |
| 392.2% | 133.1% | 85.6% | 376.3% | 74.9% | 82.5% | 109.0% | 38.8% | -281.5% | – | – | – | |
| 109.3% | -89.7% | 96.5% | 145.8% | 98.4% | -61.8% | -54.9% | -71.5% | 82.5% | -14.5% | 31.6% | 112.1% | |
| 26.6% | 6.3% | 4.4% | 15.6% | 12.0% | 4.3% | 9.2% | 6.2% | 1.1% | 4.3% | 0.5% | 0.0% | |
| -909.1% | 263.6% | -304.7% | -366.1% | 292.7% | -113.1% | 14.9% | 225.1% | 2,247.5% | -56.9% | 19.1% | -98.0% | |
| 0.0% | 0.0% | 0.0% | 0.0% | – | – | 535.9% | – | 1.6% | – | – | – | |
| -1.5% | -1.8% | -8.0% | -55.6% | -16.2% | -4.3% | -13.6% | -16.4% | -257.6% | -347.5% | -4.8% | -3.8% | |
| 1,903.6% | 528.2% | 457.4% | 1,491.2% | 380.1% | -2.9% | 177.9% | -19.4% | -1,230.1% | 0.0% | – | – | |
| 3,171.0% | 193.0% | 985.1% | 10.8% | 373.0% | 1.8% | 366.1% | 166.1% | -1,477.8% | -346.4% | -3.9% | -3.0% | |
| 3,171.0% | 55.8% | 476.9% | -1,662.1% | 478.8% | -435.8% | 32.6% | 15.4% | 405.5% | -450.4% | -2.7% | 121.0% | |
| -1,525.2% | -407.1% | -207.9% | -1,322.4% | -199.0% | -328.8% | -357.7% | -382.0% | -365.3% | -51.3% | -18.4% | 221.9% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.